Biodel Inc. · Danbury, CT United States (NASDAQ: BIOD)
Key Biodel Inc. Financials
| Company Type | Public -(NASDAQ: BIOD) Headquarters |
|---|---|
| Fiscal Year-End | September |
| 2011 Sales (mil.) | $0.0 |
| 2011 Employees | 36 |
Biodel Inc. Income Statement
| Sep 11 | Sep 10 | Sep 09 | |
| Revenue | 0.0 | 0.0 | 0.0 |
| Cost of Goods Sold | 0.0 | 0.0 | 0.0 |
| Gross Profit | 0.0 | 0.0 | 0.0 |
| Gross Profit Margin | -- | -- | -- |
| SG&A Expense | 9.3 | 11.0 | 11.0 |
| Depreciation & Amortization | 0.9 | 1.0 | 0.9 |
| Operating Income | (23.2) | (37.2) | -- |
| Operating Margin | --% | --% | --% |
| Nonoperating Income | (12.6) | 1.3 | -- |
| Nonoperating Expenses | 0.1 | 0.0 | 0.4 |
| Income Before Taxes | (10.6) | (38.4) | (42.9) |
| Income Taxes | 0.0 | (0.1) | 0.3 |
| Net Income After Taxes | (10.6) | (38.3) | (43.3) |
| Continuing Operations | (10.6) | (38.3) | (43.3) |
| Discontinued Operations | -- | -- | -- |
| Total Operations | (10.6) | (38.3) | (43.3) |
| Total Net Income | (10.6) | (38.3) | (43.3) |
| Net Profit Margin | --% | --% | --% |
| Diluted EPS from Total Net Income | (0.34) | (1.58) | (1.82) |
| Dividends per Share | -- | -- | -- |
All amounts in millions of US Dollars except per share amounts.
Biodel Inc. Balance Sheet
| Assets | Sep 11 | Sep 10 | Sep 09 |
| Current Assets | |||
| Cash | 38.7 | 22.9 | 54.6 |
| Net Receivables | 0.0 | 0.1 | 0.8 |
| Inventories | -- | -- | -- |
| Other Current Assets | 0.5 | 6.5 | 0.5 |
| Total Current Assets | 39.2 | 29.6 | 55.9 |
| Net Fixed Assets | 2.3 | 3.0 | 3.7 |
| Other Noncurrent Assets | 0.1 | 0.1 | 0.1 |
| Total Assets | 41.5 | 32.6 | 59.6 |
| Liabilities | Sep 11 | Sep 10 | Sep 09 |
| Current Liabilities | |||
| Accounts Payable | 0.2 | 2.0 | 1.0 |
| Short-Term Debt | -- | -- | -- |
| Other Current Liabilities | 3.1 | 2.4 | 8.1 |
| Total Current Liabilities | 3.3 | 4.4 | 9.1 |
| Long-Term Debt | -- | -- | -- |
| Other Noncurrent Liabilities | 1.1 | 4.2 | 0.0 |
| Total Liabilities | 4.4 | 8.6 | 9.1 |
| Shareholder's Equity | |||
| Preferred Stock Equity | 0.0 | -- | -- |
| Common Stock Equity | 37.1 | 24.1 | 50.5 |
| Total Equity | 37.1 | 24.1 | 50.5 |
| Shares Outstanding (thou.) | 38,647.7 | 26,399.8 | 23,803.7 |
All amounts in millions of US Dollars except per share amounts.
Biodel Inc. Cash Flow Statement
| Sep 11 | Sep 10 | Sep 09 | |
| Net Operating Cash Flow | (18) | (34) | (35) |
| Net Investing Cash Flow | 5.8 | (6.3) | 25.0 |
| Net Financing Cash Flow | 28.2 | 9.0 | 0.2 |
| Net Change in Cash | 15.8 | (31.7) | (10.1) |
| Depreciation & Amortization | 0.9 | 1.0 | 0.9 |
| Capital Expenditures | (0.2) | (0.3) | (0.6) |
| Cash Dividends Paid |
All amounts in millions of US Dollars except per share amounts.